TBI 📈 TrueBlue - Overview
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US89785X1019
TBI: Staffing, Recruitment, Workforce, Solutions, Services
TrueBlue, Inc., together with its subsidiaries, provides specialized workforce solutions in the United States, Canada, the United Kingdom, Australia, and Puerto Rico. It operates through three segments: PeopleReady, PeopleManagement, and PeopleScout. The company PeopleReady segment provides general, industrial, and skilled trade contingent staffing services for construction, transportation, manufacturing, retail, hospitality, and renewable energy industries. The PeopleManagement segment offers contingent, on-site industrial staffing, and commercial driver services, which includes on-site management and recruitment for the contingent industrial workforce of manufacturing, warehousing, and distribution facilities; and recruitment and management of contingent and dedicated commercial drivers to the transportation and distribution industries under the Staff Management, SIMOS Insourcing Solutions, and Centerline Drivers brands. The company PeopleScout segment provides recruitment process outsourcing, talent advisory services, and managed service provider solutions including sourcing, screening, hiring, and onboarding services; operates Affinix, a technology platform for sourcing, screening, and delivering a permanent workforce to its clients; talent advisory services, such as employer branding, recruitment marketing, talent insights, diversity, equity and inclusion consulting, candidate assessment, and talent acquisition strategy consulting services; and contingent labor programs including vendor selection, performance management, compliance monitoring, and risk management. TrueBlue, Inc. was formerly known as Labor Ready, Inc. and changed its name to TrueBlue, Inc. in December 2007. The company was incorporated in 1985 and is headquartered in Tacoma, Washington. Web URL: https://www.trueblue.com
Additional Sources for TBI Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
TBI Stock Overview
Market Cap in USD | 222m |
Sector | Industrials |
Industry | Staffing & Employment Services |
GiC Sub-Industry | Human Resource & Employment Services |
IPO / Inception | 1996-06-13 |
TBI Stock Ratings
Growth 5y | -82.6% |
Fundamental | -48.6% |
Dividend | - |
Rel. Strength Industry | -344 |
Analysts | 4/5 |
Fair Price Momentum | 6.77 USD |
Fair Price DCF | 3.04 USD |
TBI Dividends
No Dividends PaidTBI Growth Ratios
Growth Correlation 3m | 48% |
Growth Correlation 12m | -88% |
Growth Correlation 5y | -51.9% |
CAGR 5y | -19.19% |
CAGR/Mean DD 5y | -0.50 |
Sharpe Ratio 12m | -1.15 |
Alpha | -69.09 |
Beta | 0.73 |
Volatility | 41.47% |
Current Volume | 124.3k |
Average Volume 20d | 203.9k |
What is the price of TBI stocks?
As of December 27, 2024, the stock is trading at USD 8.17 with a total of 124,292 shares traded.
Over the past week, the price has changed by -1.92%, over one month by +11.76%, over three months by +9.66% and over the past year by -47.76%.
As of December 27, 2024, the stock is trading at USD 8.17 with a total of 124,292 shares traded.
Over the past week, the price has changed by -1.92%, over one month by +11.76%, over three months by +9.66% and over the past year by -47.76%.
Is TrueBlue a good stock to buy?
Probably not. Based on ValueRay Fundamental Analyses, TrueBlue (NYSE:TBI) is currently (December 2024) not a good stock to buy. It has a ValueRay Fundamental Rating of -48.56 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of TBI as of December 2024 is 6.77. This means that TBI is currently overvalued and has a potential downside of -17.14%.
Probably not. Based on ValueRay Fundamental Analyses, TrueBlue (NYSE:TBI) is currently (December 2024) not a good stock to buy. It has a ValueRay Fundamental Rating of -48.56 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of TBI as of December 2024 is 6.77. This means that TBI is currently overvalued and has a potential downside of -17.14%.
Is TBI a buy, sell or hold?
TrueBlue has received a consensus analysts rating of 4.00. Therefor, it is recommend to buy TBI.
TrueBlue has received a consensus analysts rating of 4.00. Therefor, it is recommend to buy TBI.
- Strong Buy: 1
- Buy: 1
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecast for TBI stock price target?
According to ValueRays Forecast Model, TBI TrueBlue will be worth about 7.4 in December 2025. The stock is currently trading at 8.17. This means that the stock has a potential downside of -9.79%.
According to ValueRays Forecast Model, TBI TrueBlue will be worth about 7.4 in December 2025. The stock is currently trading at 8.17. This means that the stock has a potential downside of -9.79%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 11 | 34.6% |
Analysts Target Price | 20 | 144.8% |
ValueRay Target Price | 7.4 | -9.8% |